Topic List : Infectious Disease
Drug combo effective against dengue, Ebola
To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.
Test could help prevent TB deaths
A Stanford investigator and his colleagues found that a screening test for tuberculosis was a good predictor of whether children infected with the bacteria would become sick.
Clues to why severe dengue affects some
A new study has found a specific immunologic response among people likely to get severe dengue disease. The work could help lead to a screening test for people at risk of getting a serious case of the disease and to targeted vaccines.
Study confirms existence of asymptomatic Ebola
A research team determined that 25 percent of individuals in a Sierra Leone village were infected with the Ebola virus but had no symptoms, suggesting broader transmission of the virus than originally thought.
ITI awards seed grants
Seed grants were awarded to seven faculty teams and individuals, as well as to eight young investigators, for the coming year.
Kim discusses Biohub infectious disease project
The Chan Zuckerberg Biohub will include two major research projects intended to help cure and prevent disease. One, focusing on infectious disease, will be led by biochemist Peter Kim.
How Zika affects cranial precursor cells
New research shows that cranial neural crest cells can be infected by the Zika virus, causing them to secrete high levels of cytokines that can affect neurons in the developing brain.
Proposal to expand treatment of worm infections
A study supports a greatly expanded treatment program for parasitic worm diseases that could save millions from disability and possible death in sub-Saharan Africa.
Desiree LaBeaud on the Zika virus
The infectious disease expert discusses the local risks of contracting the Zika virus, what precautions residents can take and what travelers outside the United States should do to avoid infection with the virus.
Abstinence programs don’t reduce HIV risk
In a study of nearly 500,000 individuals in 22 countries, researchers could not find any evidence that these programs had an impact on changing individual behavior.